- Home
- SPCB vs NRSN Comparison
SPCB vs NRSN Comparison
Compare SPCB & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- NRSN
- Stock Information
- Founded
- SPCB 1988
- NRSN 2017
- Country
- SPCB Israel
- NRSN Israel
- Employees
- SPCB N/A
- NRSN N/A
- Industry
- SPCB Semiconductors
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- SPCB Technology
- NRSN Health Care
- Exchange
- SPCB Nasdaq
- NRSN Nasdaq
- Market Cap
- SPCB 53.3M
- NRSN 50.1M
- IPO Year
- SPCB N/A
- NRSN 2021
- Fundamental
- Price
- SPCB $9.23
- NRSN $1.77
- Analyst Decision
- SPCB Strong Buy
- NRSN Buy
- Analyst Count
- SPCB 1
- NRSN 2
- Target Price
- SPCB $18.00
- NRSN $14.00
- AVG Volume (30 Days)
- SPCB 98.6K
- NRSN 225.6K
- Earning Date
- SPCB 08-14-2025
- NRSN 08-05-2025
- Dividend Yield
- SPCB N/A
- NRSN N/A
- EPS Growth
- SPCB N/A
- NRSN N/A
- EPS
- SPCB 1.89
- NRSN N/A
- Revenue
- SPCB $27,831,000.00
- NRSN N/A
- Revenue This Year
- SPCB $2.73
- NRSN N/A
- Revenue Next Year
- SPCB $22.87
- NRSN N/A
- P/E Ratio
- SPCB $4.76
- NRSN N/A
- Revenue Growth
- SPCB 2.90
- NRSN N/A
- 52 Week Low
- SPCB $2.55
- NRSN $0.60
- 52 Week High
- SPCB $18.95
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- SPCB 42.82
- NRSN 39.25
- Support Level
- SPCB $9.00
- NRSN $1.69
- Resistance Level
- SPCB $9.59
- NRSN $2.09
- Average True Range (ATR)
- SPCB 0.48
- NRSN 0.15
- MACD
- SPCB -0.10
- NRSN -0.04
- Stochastic Oscillator
- SPCB 14.40
- NRSN 17.78
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.